Pharmacometric modelling of risk factors for MRSA.

被引:0
|
作者
Hyatt, JM
Forrest, A
Feuerstein, S
Schentag, JJ
机构
[1] SUNY BUFFALO, SCH PHARM, BUFFALO, NY 14260 USA
[2] MILLARD FILLMORE HOSP, CLIN PHARMACOKINET LAB, BUFFALO, NY 14209 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:PII82 / PII82
页数:1
相关论文
共 50 条
  • [1] ICU demographics as a risk factor for nosocomial acquisition of MRSA.
    Srinivasan, S
    Ramsey, K
    Shulman, M
    Jimenez, V
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 57 - 57
  • [2] A View - Community Associated MRSA.
    Maheswari, S. Uma
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (04): : 3064 - 3069
  • [3] Hospital infection: From miasmas to MRSA.
    Crellin, JK
    BULLETIN OF THE HISTORY OF MEDICINE, 2005, 79 (01) : 167 - 168
  • [4] Skin infections with MRSA. Epidemiology and clinical features
    Becker, K.
    Sunderkoetter, C.
    HAUTARZT, 2012, 63 (05): : 371 - 380
  • [5] Community-based MRSA. A new challenge for dermatology
    Witte, W
    Wiese-Posselt, M
    Jappe, U
    HAUTARZT, 2005, 56 (08): : 731 - +
  • [6] Cooperative development of laboratory public health reporting for MRSA.
    不详
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (02): : 214 - 214
  • [7] Pharmacometric modelling of risk factors for ciprofloxacin resistance (Cip-R)in P-aeruginosa (Pa).
    Hyatt, JM
    Forrest, A
    Feurstein, S
    Schentag, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 199 - 199
  • [8] Risk factors associated with MRSA
    Gupta, Sonal
    Mishra, Bibhabati
    Thakur, Archana
    Dogra, Vinita
    Loomba, Poonam Sood
    Jain, Manisha
    Bhargava, Aradhana
    SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2018, 33 (03) : 76 - 79
  • [9] N-thiolated β-lactams:: A novel family of antibacterial agents for MRSA.
    Turos, E
    Long, TE
    Dickey, S
    Lim, DV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B141 - B141
  • [10] N-thiolated β-lactams:: Structurally and mechanistically novel antibacterial agents for MRSA.
    Turos, E
    Long, TE
    Heldreth, B
    Coates, CM
    Shim, JY
    Polk, J
    Konaklieva, MI
    Dickey, S
    Lim, DV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A117 - A117